The fact that RBP2 interacts with nuclear receptors and enhances expression of their target genes [86,95] suggests that RBP2 could recruit additional factors important for nuclear receptor-mediated transcription, which plays important roles in breast and prostate cancer progression. The gene discussed is RBP2; the disease is prostate carcinoma.